Colleagues,
I recently had an opportunity to participate in a podcast produced by the California Healthcare Institute (CHI). CHI is an independent organization devoted to researching and advocating policy to forward the interests of California’s biomedical community. CHI has built a membership of over 250 leading biomedical companies, academic and research institutions and companies involved in supporting the biomedical community. See links below to the podcast, information on CHI, and access to updated information on how to compete for "Stimulus" funding.
ENJOY!
CC
Conrad Clyburn, Founding Partner,The Clymer Group
Danielle Peters, Consultant, Fabiani & Company
David Gollaher, Ph.D., CEO, CHI
The Recovery Act, also known as stimulus, has stipulated $1.1 billion for comparative effectiveness research, as well as substantial funding for small startup biomedical companies. In CHI’s latest podcast, hosted by David Gollaher, Ph.D., president and CEO of CHI, he discusses with industry experts Danielle Peters of Fabiani & Company and MedTech-IQ Co-Founder,
Conrad Clyburn, and Founding Partner of Clymer Group the opportunities that now exist to find alternative forms of funding from government sources and tips for navigating the complexities of Washington and the new political landscape to help entrepreneurs find funding sources that were not previously available.
CHI podcasts feature interviews, speeches and roundtable discussions with opinion leaders in the life sciences industry. This series helps to educate the community on issues that are important to CHI members and the industry. Visit
www.chi.org or click
here to subscribe to the CHI podcast. Click
here for additional resources to find funding. Click
here for the transcript of the podcast.
You need to be a member of MedTech I.Q. to add comments!
Join MedTech I.Q.